Status:

COMPLETED

Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

Lead Sponsor:

National Jewish Health

Collaborating Sponsors:

Mordecai Palliative Care Research Fund

Conditions:

Idiopathic Pulmonary Fibrosis

Eligibility:

All Genders

40-90 years

Phase:

NA

Brief Summary

The purpose of this study is to determine the effects of Pulmonary Rehabilitation (PR) on shortness of breath, exercise capacity, symptom control, mental health, cognitive function, and quality of lif...

Detailed Description

The goals of this project are to assess the effect of PR on a number of important outcomes in patients with IPF. Once enrolled in the study, subjects will complete a battery of questionnaires and test...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Age 40 years or older
  • Diagnosis of IPF according to American Thoracic Society criteria
  • Exclusion criteria:
  • Patients who have completed a PR program within the last two years
  • Patients with unstable medical conditions that would make PR unsafe

Exclusion

    Key Trial Info

    Start Date :

    April 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 1 2010

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT00692796

    Start Date

    April 1 2008

    End Date

    March 1 2010

    Last Update

    March 29 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Jewish Medical and Research Center

    Denver, Colorado, United States, 80206